• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大辅助疗法的作用:狼疮性肾炎的案例

Expanding the Role of Complement Therapies: The Case for Lupus Nephritis.

作者信息

Li Nicholas L, Birmingham Daniel J, Rovin Brad H

机构信息

Department of Internal Medicine, Division of Nephrology, The Ohio State University, Columbus, OH 43210, USA.

出版信息

J Clin Med. 2021 Feb 7;10(4):626. doi: 10.3390/jcm10040626.

DOI:10.3390/jcm10040626
PMID:33562189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7915321/
Abstract

The complement system is an innate immune surveillance network that provides defense against microorganisms and clearance of immune complexes and cellular debris and bridges innate and adaptive immunity. In the context of autoimmune disease, activation and dysregulation of complement can lead to uncontrolled inflammation and organ damage, especially to the kidney. Systemic lupus erythematosus (SLE) is characterized by loss of tolerance, autoantibody production, and immune complex deposition in tissues including the kidney, with inflammatory consequences. Effective clearance of immune complexes and cellular waste by early complement components protects against the development of lupus nephritis, while uncontrolled activation of complement, especially the alternative pathway, promotes kidney damage in SLE. Therefore, complement plays a dual role in the pathogenesis of lupus nephritis. Improved understanding of the contribution of the various complement pathways to the development of kidney disease in SLE has created an opportunity to target the complement system with novel therapies to improve outcomes in lupus nephritis. In this review, we explore the interactions between complement and the kidney in SLE and their implications for the treatment of lupus nephritis.

摘要

补体系统是一个先天性免疫监测网络,可抵御微生物、清除免疫复合物和细胞碎片,并连接先天性免疫和适应性免疫。在自身免疫性疾病的背景下,补体的激活和失调会导致不受控制的炎症和器官损伤,尤其是对肾脏的损伤。系统性红斑狼疮(SLE)的特征是耐受性丧失、自身抗体产生以及免疫复合物在包括肾脏在内的组织中沉积,并伴有炎症后果。早期补体成分有效清除免疫复合物和细胞废物可预防狼疮性肾炎的发生,而补体的不受控制激活,尤其是替代途径的激活,会促进SLE患者的肾脏损伤。因此,补体在狼疮性肾炎的发病机制中起双重作用。对各种补体途径在SLE肾病发展中的作用的进一步了解,为采用新疗法靶向补体系统以改善狼疮性肾炎的治疗效果创造了机会。在本综述中,我们探讨了SLE中补体与肾脏之间的相互作用及其对狼疮性肾炎治疗的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f09/7915321/7919c698b800/jcm-10-00626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f09/7915321/7919c698b800/jcm-10-00626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f09/7915321/7919c698b800/jcm-10-00626-g001.jpg

相似文献

1
Expanding the Role of Complement Therapies: The Case for Lupus Nephritis.扩大辅助疗法的作用:狼疮性肾炎的案例
J Clin Med. 2021 Feb 7;10(4):626. doi: 10.3390/jcm10040626.
2
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies.从系统性红斑狼疮到狼疮性肾炎:靶向治疗的演进之路
Autoimmun Rev. 2023 Oct;22(10):103404. doi: 10.1016/j.autrev.2023.103404. Epub 2023 Aug 3.
3
Genetics of Lupus Nephritis: Clinical Implications.狼疮性肾炎的遗传学:临床意义
Semin Nephrol. 2015 Sep;35(5):396-409. doi: 10.1016/j.semnephrol.2015.08.002.
4
Revisiting the complement system in systemic lupus erythematosus.重新审视系统性红斑狼疮中的补体系统。
Expert Rev Clin Immunol. 2020 Apr;16(4):397-408. doi: 10.1080/1744666X.2020.1745063. Epub 2020 Apr 6.
5
Complement in Lupus Nephritis: New Perspectives.狼疮性肾炎的补体:新视角。
Kidney Dis (Basel). 2015 Sep;1(2):91-9. doi: 10.1159/000431278. Epub 2015 Jun 30.
6
The Complement System in Lupus Nephritis.狼疮性肾炎中的补体系统
Semin Nephrol. 2015 Sep;35(5):444-54. doi: 10.1016/j.semnephrol.2015.08.006.
7
Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.T细胞中磷酸酶JKAP/DUSP22的下调作为系统性红斑狼疮性肾炎潜在的新生物标志物
Oncotarget. 2016 Sep 6;7(36):57593-57605. doi: 10.18632/oncotarget.11419.
8
Lupus nephritis: from pathogenesis to targets for biologic treatment.狼疮性肾炎:从发病机制到生物治疗靶点
Nephron Clin Pract. 2014;128(3-4):224-31. doi: 10.1159/000368581. Epub 2014 Nov 8.
9
The role of anticomplement therapy in lupus nephritis.抗补体治疗在狼疮肾炎中的作用。
Transl Res. 2022 Jul;245:1-17. doi: 10.1016/j.trsl.2022.02.001. Epub 2022 Feb 11.
10
The role of the alternative pathway of complement activation in glomerular diseases.补体激活旁路在肾小球疾病中的作用。
Clin Exp Med. 2018 Aug;18(3):297-318. doi: 10.1007/s10238-018-0491-8. Epub 2018 Feb 15.

引用本文的文献

1
Systemic lupus erythematosus as the paradigm for understanding the complex immune relationships and therapeutic opportunities for targeting complement in autoimmune diseases.系统性红斑狼疮作为理解自身免疫性疾病中复杂免疫关系以及补体靶向治疗机会的范例。
Immunobiology. 2025 May;230(3):152915. doi: 10.1016/j.imbio.2025.152915. Epub 2025 May 20.
2
scPrediXcan integrates deep learning methods and single-cell data into a cell-type-specific transcriptome-wide association study framework.scPrediXcan将深度学习方法和单细胞数据整合到特定细胞类型的全转录组关联研究框架中。
Cell Genom. 2025 May 14;5(5):100875. doi: 10.1016/j.xgen.2025.100875.
3

本文引用的文献

1
Association of MBL-2 gene polymorphisms with systemic lupus erythematosus: an updated meta-analysis and trial sequential analysis.甘露聚糖结合凝集素2(MBL-2)基因多态性与系统性红斑狼疮的关联:一项更新的荟萃分析和试验序贯分析
Lupus. 2020 Sep;29(10):1227-1237. doi: 10.1177/0961203320939156. Epub 2020 Jul 7.
2
A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.系统性红斑狼疮相关性血栓性微血管病中依库珠单抗作用的系统评价。
BMC Nephrol. 2020 Jun 30;21(1):245. doi: 10.1186/s12882-020-01888-5.
3
Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis.
New Insights on Childhood Lupus Nephritis.
儿童狼疮性肾炎的新见解
Int J Nephrol Renovasc Dis. 2025 Jan 13;18:1-12. doi: 10.2147/IJNRD.S405789. eCollection 2025.
4
scPrediXcan integrates advances in deep learning and single-cell data into a powerful cell-type-specific transcriptome-wide association study framework.scPrediXcan将深度学习和单细胞数据方面的进展整合到一个强大的细胞类型特异性全转录组关联研究框架中。
bioRxiv. 2025 Mar 4:2024.11.11.623049. doi: 10.1101/2024.11.11.623049.
5
Lupus nephritis-related chronic kidney disease.狼疮肾炎相关的慢性肾脏病。
Nat Rev Rheumatol. 2024 Nov;20(11):699-711. doi: 10.1038/s41584-024-01158-w. Epub 2024 Sep 24.
6
Lupus Nephritis from Pathogenesis to New Therapies: An Update.狼疮性肾炎:从发病机制到新疗法的研究进展。
Int J Mol Sci. 2024 Aug 18;25(16):8981. doi: 10.3390/ijms25168981.
7
Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression.原发性抗磷脂综合征的肾脏全转录组谱分析显示补体、干扰素和 NETs 相关基因表达。
Rheumatology (Oxford). 2024 Nov 1;63(11):3184-3190. doi: 10.1093/rheumatology/keae397.
8
Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases.培克妥昔单抗在C3肾小球病和其他补体介导的肾小球疾病患者2期研究中的临床安全性和有效性。
Kidney Int Rep. 2023 Aug 25;8(11):2284-2293. doi: 10.1016/j.ekir.2023.08.033. eCollection 2023 Nov.
9
Regulatory T cell adoptive transfer alters uterine immune populations, increasing a novel MHC-II macrophage associated with healthy pregnancy.调节性 T 细胞过继转移改变了子宫免疫群体,增加了一种与健康妊娠相关的新型 MHC-II 巨噬细胞。
Front Immunol. 2023 Oct 13;14:1256453. doi: 10.3389/fimmu.2023.1256453. eCollection 2023.
10
Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients.尿液蛋白质组学将补体激活与狼疮肾炎患者的间质纤维化/肾小管萎缩联系起来。
Semin Arthritis Rheum. 2023 Dec;63:152263. doi: 10.1016/j.semarthrit.2023.152263. Epub 2023 Sep 27.
补体替代途径的激活可预测狼疮肾炎患者的肾脏结局。
Lupus. 2020 Jul;29(8):862-871. doi: 10.1177/0961203320925165. Epub 2020 May 14.
4
Discovery of 4-((2,4)-4-Ethoxy-1-((5-methoxy-7-methyl-1-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases.发现 4-((2,4)-4-乙氧基-1-((5-甲氧基-7-甲基-1-吲哚-4-基)甲基)哌啶-2-基)苯甲酸(LNP023),一种专门设计用于治疗多种补体介导疾病的因子 B 抑制剂。
J Med Chem. 2020 Jun 11;63(11):5697-5722. doi: 10.1021/acs.jmedchem.9b01870. Epub 2020 Feb 19.
5
Discovery and Development of the Oral Complement Factor D Inhibitor Danicopan (ACH-4471).口服补体因子 D 抑制剂 Danicopan(ACH-4471)的发现和开发。
Curr Med Chem. 2020;27(25):4165-4180. doi: 10.2174/0929867326666191001130342.
6
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity.补体受体 C5aR2:先天和适应性免疫的强大调节剂。
J Immunol. 2019 Jun 15;202(12):3339-3348. doi: 10.4049/jimmunol.1900371.
7
Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.肾小球膜攻击复合物不是狼疮性肾炎中 C5 持续激活的可靠标志物。
Kidney Int. 2019 Mar;95(3):655-665. doi: 10.1016/j.kint.2018.09.027. Epub 2019 Jan 14.
8
A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy.一项前瞻性观察性队列研究强调了维持治疗停药后出现复发的狼疮肾炎缓解患者的肾活检结果。
Kidney Int. 2018 Oct;94(4):788-794. doi: 10.1016/j.kint.2018.05.021. Epub 2018 Jul 23.
9
Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells.钙调磷酸酶抑制剂诱导的补体系统激活通过 ERK1/2 信号通路被 SOCS-3 在人肾小管细胞中抑制。
Eur J Immunol. 2018 Feb;48(2):330-343. doi: 10.1002/eji.201747135. Epub 2017 Dec 11.
10
Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement.免疫介导性肾小球疾病的遗传学:聚焦于补体。
Semin Nephrol. 2017 Sep;37(5):447-463. doi: 10.1016/j.semnephrol.2017.05.018.